1,606
Views
4
CrossRef citations to date
0
Altmetric
Benchmarks

Replacement of Osmotic Minipumps to Extend the Intracerebral Infusion time of Compounds into the Mouse Brain

&
Pages 75-78 | Received 18 Mar 2013, Accepted 12 Jul 2013, Published online: 03 Apr 2018

References

  • Yates, F.E., H.Benson, R.Buckles, J.Urquhart, and A.Zaffaroni. 1975. Engineering development of therapeutic systems: a new class of dosage forms for the controlled delivery of drugs.Adv Biomed Eng.5:1–34.
  • Theeuwes, F. and S.I.Yum. 1976. Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations.Ann. Biomed. Eng.4:343–353.
  • de la Torre, J.C. and M.Gonzalez-Carvajal. 1981. Steady state drug or fluid delivery to injured or transected spinal cord of rats.Lab. Anim. Sci.31:701–703.
  • Pettigrew, J.D. and T.Kasamatsu. 1978. Local perfusion of noradrenaline maintains visual cortical plasticity.Nature271:761–763.
  • Williams, L.R., H.L.Vahlsing, T.Lindamood, S.Varon, F.H.Gage, and M.Manthorpe. 1987. A small-gauge cannula device for continuous infusion of exogenous agents into the brain.Exp. Neurol.95:743–754.
  • Rothman, R.B., L.S.Brady, H.Xu, and J.B.Long. 1993. Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain.Peptides14:1271–1277.
  • Banach-Petrosky, W., W.J.Jessen, X.Ouyang, H.Gao, J.Rao, J.Quinn, B.J.Aronow, and C.Abate-Shen. 2007. Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice.Cancer Res.67:9089–9096.
  • Tamagawa, M., H.Keino, M.Taniguchi, J.Morita, and I.Naruse. 1994. Induction of the hydrocephalus by the intraventricular injection of aurintricarboxylic acid in mice exo utero.Cong. Anom.34:345–352.
  • Stohs, S.J. and D.Bagchi. 1995. Oxidative mechanisms in the toxicity of metal ions.Free Radic. Biol. Med.18:321–336.
  • Valko, M., H.Morris, and M.T.Cronin. 2005. Metals, toxicity and oxidative stress.Curr. Med. Chem.12:1161–1208.
  • Heppner, F.L., M.Greter, D.Marino, J.Falsig, G.Raivich, N.Hovelmeyer, A.Waisman, T.Rulicke, et al.. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis.Nat. Med.11:146–152.
  • Grathwohl, S.A., R.E.Kalin, T.Bolmont, S.Prokop, G.Winkelmann, S.A.Kaeser, J.Odenthal, R.Radde, et al.. 2009. Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia.Nat. Neurosci.12:1361–1363.
  • Long, J.M., P.R.Mouton, M.Jucker, and D.K.Ingram. 1999. What counts in brain aging? Design-based stereological analysis of cell number.J. Gerontol. A Biol. Sci. Med. Sci.54:B407–B417.
  • Varvel, N.H., S.A.Grathwohl, F.Baumann, C.Liebig, A.Bosch, B.Brawek, D.R.Thal, I.F.Charo, et al.. 2012. Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells.Proc. Natl. Acad. Sci. USA109:18150–18155.
  • Abe, C., T.Tashiro, K.Tanaka, R.Ogihara, and H.Morita. 2009. A novel type of implantable and programmable infusion pump for small laboratory animals.J. Pharmacol. Toxicol. Methods59:7–12.
  • Jacobs, S., E.Ruusuvuori, S.T.Sipila, A.Haapanen, H.H.Damkier, I.Kurth, M.Hentschke, M.Schweizer, et al.. 2008. Mice with targeted Slc4a10 gene disruption have small brain ventricles and show reduced neuronal excitability.Proc. Natl. Acad. Sci. USA105:311–316.